ISRCTN31486124已完成不适用
Treatment of advanced, relapsed chronic lymphocytic leukemia (CLL) with fludarabine, miroxantrone and cyclophosphamide combination therapy with or without granulocyte colony stimulating factor (G-CSF)
German CLL Study Group (GCLLSG) (Germany)0 个研究点目标入组 165 人开始时间: 2005年10月11日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 165
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 性别
- All
入选标准
- •1. B-cell chronic lymphocytic leukemia (B-CLL)
- •2. Binet stage C, Binet stage B with treatment indication
- •3. Maximum of 3 previous treatment regimen
- •4. Age 18-70 years
- •5. Life expectancy more than 6 months
- •6. Eastern Cooperative Oncology Group (ECOG) 0-3
- •7. Normal cardiac function
- •8. Signed inform consent
排除标准
- •1. Severe organ dysfunction
- •2. Autoimmune haemolytic anaemia (AIHA)
- •3. More than 3 chemotherapy regimens
- •4. Concomitant or previous neoplasm
- •5. Non-response to previous treatment with Fludarabine + Cyclophosphamide, Fludarabine + Mitoxantrone, Fludarabine + Epirubicine
研究者
相似试验
进行中（未招募）
1 期
Treatment of blood cancer with the use of a drug active against herpesvirusesChronic lymphocytic leukemiaMedDRA version: 14.1Level: LLTClassification code 10008976Term: Chronic lymphocytic leukemiaSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)EUCTR2010-021786-78-ATMedizinische Universität Wien
已完成
2 期
Treatment protocol for adult acute lymphocytic leukemia -ALL/ MRD2008adult acute lymphocytic leukemiaJPRN-UMIN000001519Fukuoka Blood & Marrow Transplant Group20
进行中（未招募）
不适用
Treatment in patients with recurrent infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response. - Treatment of IgG Subclass Deficiency and/or Deficiency of Anti-Polysaccharide Antibody ResponseEstablished diagnosis of IgG subclass deficiency, and/or (selective) antipolysaccharide antibody deficiency.MedDRA version: 8.1Level: LLTClassification code 10021275Term: IgG subclass deficiencyEUCTR2006-005215-98-NLSanquin Plasma Products
已完成
4 期
Treatment in patients with recurrent infections and IgG Subclass Deficiency, and/or Deficient Anti-Polysaccharide Antibody Response.antibody deficiency1002146010024970NL-OMON35384Sanquin Plasmaproducten60
招募中
2 期
Treatment protocol for adult acute lymphoblastic leukemia (-ALL/MRD2023-)acute lymphoblastic leukemiaJPRN-jRCTs071220071Koichi Akashi210